SuO-Val-Cit-PAB-MMAE |
| Catalog No.GC34380 |
SuO-Val-Cit-PAB-MMAE est un conjugué médicament-lieur pour l'ADC utilisant l'agent anti-mitotique, la monométhylauristatine E (MMAE, un inhibiteur de la tubuline), lié via le peptide SuO-Val-Cit-PAB.
Products are for research use only. Not for human use. We do not sell to patients.
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
SuO-Val-Cit-PAB-MMAE is a drug-linker conjugate for ADC by using the anti-mitotic agent, monomethyl auristatin E (MMAE), linked via the peptide SuO-Val-Cit-PAB.
Review for SuO-Val-Cit-PAB-MMAE
Average Rating: 5 (Based on Reviews and 13 reference(s) in Google Scholar.)
Review for SuO-Val-Cit-PAB-MMAE
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *